Amarin Corp Plc (AMRN)

[Biobillionair]

The importance of IP protection: Abilify example

Abilify 2012 generated about $6 Billion dollars, no generic available. It was approved by the FDA 2002, obviously it's five years are up.

Abilify has two patent listed in OB 5006528 and 5006528 Peds. First patent expiring Oct 2014.

It's not the 5 yr that held of generics of this multi $Billion drug, it's one patent number...ONE.